Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
European Journal of Radiology|December 29, 2016
Prognostic value of CT-derived left atrial and left ventricular measures in patients with acute chest painRichard A P Takx, Rozemarijn Vliegenthart, U Joseph Schoepf, et al.American Journal of Physiology. Heart and Circulatory Physiology|October 26, 2010
Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overloadJ David Symons, Ping Hu, Ying Yang, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 2025
Device Therapy for Heart Failure With Preserved Ejection Fraction: The Problem, the Mechanism, the Device, the TrialScott M Lilly, Firas Zahr, Mark N Belkin, et al.Cell Metabolism|December 2, 2008
Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1Ningning Wang, Guangrui Yang, Zhanjun Jia, et al.Journal of Molecular and Cellular Cardiology|May 26, 2015
Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndromeOlesya Ilkun, Nicole Wilde, Joseph Tuinei, et al.European Journal of Heart Failure|June 26, 2024
A novel controlled metabolic accelerator for the treatment of obesity-related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trialDalane W Kitzman, Gregory D Lewis, Ambarish Pandey, et al.Molecular Endocrinology (Baltimore, Md.)|September 20, 2008
Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophyJaetaek Kim, Adam R Wende, Sandra Sena, et al.Endocrinology|September 8, 2007
Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signalingSandra Sena, Isaac R Rasmussen, Adam R Wende, et al.Cardiovascular Research|June 14, 2013
Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathySankaranarayanan Kannan, Vasanthi R Muthusamy, Kevin J Whitehead, et al.Journal of the American College of Cardiology|September 3, 2025
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based AnalysisMilton Packer, Michael R Zile, Christopher M Kramer, et al.Pageof 14